Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) came under pressure in the premarket on Tuesday after the company’s Q1 2025 ...

In recent shareholder letters, we have been highlighting market anecdotes illustrating speculative behavior across financial ...

JetBlue (NASDAQ:JBLU) on Tuesday took a step back from reiterating the full-year forecast it previously provided, citing ...

India’s Initial Public Offering (IPO) market continues to demonstrate resilience, securing a 22 per cent share of global IPO ...

Spotify stock is up 106.4% year over year and 33.6% year to date. The equity is looking to extend yesterday’s 3.7% dip, which ...

Kraft Heinz now forecasts an up to 3.5% decline in its full year organic net sales, this is in contrast with a previous “flat ...

META's earnings are coming up! Discover the balance between upside potential and downside risk, and how it shifts from short- ...

We recently published a list of 12 Large-Cap Stocks Insiders Were Buying in Q1 2025 Before Trump’s Tariff Shockwave.

Shopping mall operator SM Prime Holdings Inc. on Tuesday said its net income in the first quarter grew 11 percent to P11.9 billion from the previous year’s P10.7 billion, which it attributed to steady ...

SNB Capital said Yanbu National Petrochemical Co. (Yansab) reported weak results for the first quarter of 2025 as net income ...

Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a closer look.

The company, which makes residential and commercial water heaters, boilers, tanks and treatment products, posted a 2 per cent fall in quarterly sales to $963.9 million ...